Dermatomyositis in the pediatric patient

Area of Science:

• Pediatric Rheumatology
• Dermatology
• Neuromuscular Disorders

Background:

• Dermatomyositis is a rare autoimmune disease affecting children.
• It presents with characteristic muscle weakness and skin rash.
• Long-term outcomes and treatment efficacy require further investigation.

Purpose of the Study:

• To evaluate the long-term efficacy of corticosteroid treatment in pediatric dermatomyositis.
• To assess the functional disability and prognosis in a cohort of children with dermatomyositis.
• To analyze the diagnostic value of clinical and laboratory findings.

Main Methods:

• Retrospective analysis of 41 children diagnosed with dermatomyositis.
• Treatment included corticosteroids and individualized physical therapy.
• Follow-up over a 15-year period.
• Assessment of clinical symptoms, serum muscle enzymes, electromyography, and muscle biopsy.

Main Results:

• All patients experienced progressive proximal muscle weakness; 60% reported muscle pain.
• Classic skin rash present in 33 children at diagnosis.
• Serum muscle enzymes, EMG, and biopsy confirmed acute myositis.
• Good prognosis with minimal functional disability observed.
• Three deaths recorded, one definitively linked to dermatomyositis.

Conclusions:

• Adrenal corticosteroid therapy, alongside physical therapy and consistent follow-up, is effective for pediatric dermatomyositis.
• The disease course indicates a favorable prognosis for both survival and functional outcomes.
• Early diagnosis and comprehensive management are crucial for improving patient outcomes.